Clinical Trials Logo

Clinical Trial Summary

Hopelessness is associated with 3.4 times increased risk of mortality or nonfatal myocardial infarction in patients with ischemic heart disease (IHD), independent of depression. Hopelessness has been identified in 27-52% of patients with IHD and can persist for up to 12 months after hospital discharge. Hopelessness, a negative outlook and sense of helplessness toward the future, can be a temporary response to an event (state) or a habitual outlook (trait). Hopelessness is associated with decreased physical functioning and lower physical activity (PA) levels in individuals with IHD. Low levels of PA independently contribute to increased death and adverse events in patients with IHD. Rates of PA in IHD patients continue to be unacceptably low in both hospital-based cardiac rehabilitation and home settings. Compounding this issue is often the symptom of hopelessness. The links among hopelessness, PA and mortality and morbidity for patients with IHD remain largely unknown, especially in rural and minority IHD patients. The purpose of this study is to delineate differences in hopelessness between urban and rural patients with IHD, as well as between racial minority, including Hispanic and Native American, and White patients with IHD. Potential mediation of urbanicity and race/ethnicity by social connectedness, a key variable in rural settings, will also be examined. A 6-month longitudinal study will be conducted at Sanford Heart Hospital and Avera Health in Sioux Falls, South Dakota. Hopelessness will be measured using the State-Trait Hopelessness Scale. The results of this study have potential to transform nursing practice by providing a better understanding of hopelessness in IHD patients and informing future exercise rehabilitation studies and interventions in rural and minority populations.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04498975
Study type Observational
Source Dordt University
Contact
Status Completed
Phase
Start date June 1, 2018
Completion date August 1, 2020

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT05064293 - Assisted Identification and Navigation of Early Mental Health Symptoms in Children N/A
Not yet recruiting NCT05886595 - Being Young : My Mental Health
Active, not recruiting NCT05903638 - A Pilot RCT: the Impact of a Virtual MBSR Course on Women With Primary Infertility N/A
Not yet recruiting NCT04030858 - The INFINITE Study: A Prospective Investigation of a Nutrient-dense Diet in Early Addiction Recovery N/A
Recruiting NCT04926675 - Development of a Money Advice Intervention Within IAPT N/A
Recruiting NCT06105970 - Chinese Community Sample of Hierarchical Model of Psychopathology
Recruiting NCT06038721 - Unified Protocol: Community Connections N/A
Completed NCT05056428 - Effects of Mindfulness Training on Emotional Care Strategies N/A
Not yet recruiting NCT04978194 - Effects of an Intervention on University Students' Mental Health and Learning During COVID-19 N/A
Recruiting NCT06144905 - Norwegian Microbiota Study in Anorexia Nervosa
Completed NCT06080685 - Efficacy of Character Strengths Intervention in Enhancing Character Strengths and Self-esteem Among Adolescents N/A
Not yet recruiting NCT06430853 - Psychobiological Interventions in Pregnancy N/A
Not yet recruiting NCT06187701 - Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients N/A
Not yet recruiting NCT06266936 - Smart Life Smart Living Intercontinental - Medical Students' Cohort
Not yet recruiting NCT05979649 - An Internet-Based Intervention With Peer Support for the Mental Health of Youths N/A
Not yet recruiting NCT06006936 - Testing an Evidence-Based Self-Help Program for Infertility-Related Distress in Women N/A
Recruiting NCT05492305 - Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health
Not yet recruiting NCT05316948 - Mental Health and Sexuality in Adolescents and Young Adults
Completed NCT05598697 - Economic Evaluation of the MEWE Intervention N/A